Tag: U.S. Food and Drug Administration
Filter by:
First Kidney Transplant From A Genetically Modif...
At the outset of RMS LifeRisks longevity modeling in 2007, one potential advance (vitagion) identified on the medical horizon was…
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…